1. Patient information leaflets for Transrectal Ultrasound guided prostate biopsy: Results of North Thames deanery survey
- Author
-
Claire Phipps, Kishore Bahl, Muhammad Farjad, Iqbal Shergill, and George Fowlis
- Subjects
medicine.medical_specialty ,Package insert ,medicine.medical_treatment ,Short Report ,lcsh:Medicine ,General Biochemistry, Genetics and Molecular Biology ,Support group ,Haematospermia ,Patient information ,medicine ,lcsh:Science (General) ,lcsh:QH301-705.5 ,Gynecology ,Medicine(all) ,business.industry ,Urinary retention ,Biochemistry, Genetics and Molecular Biology(all) ,General surgery ,lcsh:R ,General Medicine ,Checklist ,Ultrasound-Guided Prostate Biopsy ,Postal survey ,lcsh:Biology (General) ,lipids (amino acids, peptides, and proteins) ,medicine.symptom ,business ,lcsh:Q1-390 - Abstract
Background We evaluated the quality of patient information leaflets for Trans-Rectal Ultrasound guided prostate biopsies (TRUS-Bx) in North Thames region. TRUS-Bx information leaflets were requested from 24 hospitals in the region. All hospitals were contacted by telephone, and non-responders were followed-up by postal survey. Leaflets received were evaluated for a clear description of the procedure, directions to TRUS-Bx location, a clear description of the procedure, contact for queries/concerns, information about preparation prior to procedure, information about regular medication, information on how to obtain results, instructions for follow-up arrangements, analgesia used and risk of morbidity/mortality. Additionally, the leaflets were evaluated for diagrams to clarify the procedure and the anatomy, and sources of additional information, such as reference to published articles or prostate cancer patient support groups/internet websites. Findings In summary, a total of 17 leaflets (77%) were received. Of these, the majority (94%) had a clear description of the procedure, contact for queries/concerns (82%), information about preparation prior to TRUS-Bx (71%). Directions to TRUS-Bx location (29%), and analgesia used (35%), was very poorly described, and information on obtaining results and follow-up arrangements were described in only 12 (71%) leaflets. Complications such as risks of infection, haematuria, haematospermia and rectal bleeding, were generally explained (71%-76% of leaflets), urinary retention was mentioned in only 5 (29%) leaflets and mortality in only 1 case. Descriptive diagrams of the procedure and prostate anatomy were very rarely used, and sources of additional information were limited to 1 published article and reference to 1 prostate cancer support group. Conclusions This study demonstrates that there is large variation in the information supplied in TRUS-Bx patient information leaflets in the North Thames region, with some leaflets lacking vital information. It is proposed that a standard patient information leaflet incorporating all the factors in the checklist should be designed, with the incorporation of a new BAUS procedure specific consent form for TRUS-Bx.
- Published
- 2010